Abcam Opens New Hub In Singapore

Its new home will support the Asia Pacific (APAC) region, which accounts for 30% of all global pharmaceutical spending

AsianScientist (Apr. 28, 2022)– Abcam, a global innovator working  together with life scientists to advance research and enable faster breakthroughs, officially opened its newest regional hub in Singapore on April 27.

With healthcare expenditure in Asia projected to grow by 135% to USD 2.3 trillion in 2026, the life sciences sector in the region continues to expand rapidly. Abcam’s new site will service the growing APAC life sciences community, offering scientific and technical support and providing a commercial headquarters for the region.

“For the past two decades, we have witnessed how the quality of science, investment in R&D, and growing presence of world-class talent have made APAC a central place to drive innovation and advances in life science and healthcare,” said Alan Hirzel, CEO at Abcam. “We’re excited to be at the heart of the dynamic life sciences ecosystem in Singapore. The new regional hub will strengthen our interactions with researchers in APAC and will help the global life sciences community push the boundaries of research.”

At its new base at the Biopolis Biomedical Research Hub—just a stone’s throw from some of the region’s leading research centers—Abcam joins over 350 life sciences companies, including eight of the top 10 global pharma players, which have laid down roots in the country.

“We are pleased that Abcam has chosen Singapore as the location of its new APAC hub,” said Ms Junie Fo, Vice President, Investment Facilitation, Singapore Economic Development Board. “We are confident that by tapping into our vibrant healthcare and innovation ecosystems, Abcam will be able to support the life sciences community in Singapore to meet the region’s growing healthcare needs.”

The official opening ceremony was graced by Guest-of-Honor Professor Tan Sze Wee, Assistant Chief Executive of Enterprise at Singapore’s Agency for Science, Technology and Research (A*STAR), alongside members of Abcam’s Executive Leadership team. This move marks a major milestone in Abcam’s growth, building on its recent expansion in Shanghai and Hangzhou (which continues to serve customers in mainland China) and Adelaide, Australia.

Photo: Daniel Kuan.
Disclaimer: AsianScientist is a media partner of Abcam for the launch of its APAC hub in Singapore. This article does not necessarily reflect the views of AsianScientist or its staff.

Asian Scientist Magazine is an award-winning science and technology magazine that highlights R&D news stories from Asia to a global audience. The magazine is published by Singapore-headquartered Wildtype Media Group.

Related Stories from Asian Scientist